Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 6
Submit an article Journal homepage
1,465
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus – Research Paper

Message testing in India for COVID-19 vaccine uptake: What appeal and what messenger are most persuasive?

Rupali J. Limayea Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;b International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;c Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;d Department of Health, Behavior & Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3883-9720View further author information
ORCID Icon,
Daniel J. Erchicka Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAView further author information
,
Kristian Balgobind Department of Health, Behavior & Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAView further author information
,
Alexandra Michela Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;b International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAView further author information
&
Gretchen Schulze Department of Population, Family, and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAView further author information
Article: 2091864 | Received 03 Mar 2022, Accepted 15 Jun 2022, Published online: 13 Jul 2022

Figures & data

Figure 1. Participant flowchart.

Figure 1. Participant flowchart.

Table 1. Participant characteristics and prevalence of vaccine hesitancy (n = 534).

Table 2. Participant preferences for message aspects across six ads.

Figure 2. Participant ad preference overall and stratified by vaccine hesitancy status.

Figure 2. Participant ad preference overall and stratified by vaccine hesitancy status.

Table 3. Relative risk ratios of ad preference by vaccine hesitancy status and participant characteristics using multivariable multinomial logistic regression modeling.

Figure 3. Participant ranking of COVID-19 vaccine concerns. Responses were 1, highest level of concern, to 6, lowest level of concern.

Figure 3. Participant ranking of COVID-19 vaccine concerns. Responses were 1, highest level of concern, to 6, lowest level of concern.

Table

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.